Multiple facets in the control of acromegaly

Q2

Autores:
Vilar, Lucio
Valenzuela, Alex
Ribeiro-Oliveira Jr, Antônio
Gomez Giraldo, Claudia Milena
Pantoja, Doly
Bronstein, Marcello D
Tipo de recurso:
Article of journal
Fecha de publicación:
2013
Institución:
Pontificia Universidad Javeriana
Repositorio:
Repositorio Universidad Javeriana
Idioma:
eng
OAI Identifier:
oai:repository.javeriana.edu.co:10554/53508
Acceso en línea:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906559/
http://hdl.handle.net/10554/53508
https://doi.org/10.1007/s11102-013-0536-7
Palabra clave:
Acromegaly
Pituitary
Latin America
GH
IGF-1
Tumor shrinkage
Comorbidities
Somatostatin analogs
Rights
License
Atribución-NoComercial 4.0 Internacional
id JAVERIANA2_d195f9a511a1ab28d0a425b46ed40f51
oai_identifier_str oai:repository.javeriana.edu.co:10554/53508
network_acronym_str JAVERIANA2
network_name_str Repositorio Universidad Javeriana
repository_id_str
dc.title.spa.fl_str_mv Multiple facets in the control of acromegaly
title Multiple facets in the control of acromegaly
spellingShingle Multiple facets in the control of acromegaly
Acromegaly
Pituitary
Latin America
GH
IGF-1
Tumor shrinkage
Comorbidities
Somatostatin analogs
title_short Multiple facets in the control of acromegaly
title_full Multiple facets in the control of acromegaly
title_fullStr Multiple facets in the control of acromegaly
title_full_unstemmed Multiple facets in the control of acromegaly
title_sort Multiple facets in the control of acromegaly
dc.creator.fl_str_mv Vilar, Lucio
Valenzuela, Alex
Ribeiro-Oliveira Jr, Antônio
Gomez Giraldo, Claudia Milena
Pantoja, Doly
Bronstein, Marcello D
dc.contributor.author.none.fl_str_mv Vilar, Lucio
Valenzuela, Alex
Ribeiro-Oliveira Jr, Antônio
Gomez Giraldo, Claudia Milena
Pantoja, Doly
Bronstein, Marcello D
dc.contributor.corporatename.none.fl_str_mv Pontificia Universidad Javeriana. Facultad de Medicina. Departamento de Endocrinología
dc.subject.keyword.spa.fl_str_mv Acromegaly
Pituitary
Latin America
GH
IGF-1
Tumor shrinkage
Comorbidities
Somatostatin analogs
topic Acromegaly
Pituitary
Latin America
GH
IGF-1
Tumor shrinkage
Comorbidities
Somatostatin analogs
description Q2
publishDate 2013
dc.date.created.none.fl_str_mv 2013-11-23
dc.date.accessioned.none.fl_str_mv 2021-04-13T02:08:01Z
dc.date.available.none.fl_str_mv 2021-04-13T02:08:01Z
dc.type.local.spa.fl_str_mv Artículo de revista
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
format http://purl.org/coar/resource_type/c_6501
dc.identifier.spa.fl_str_mv https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906559/
dc.identifier.issn.spa.fl_str_mv 1386-341X / 1573-7403 (Electrónico)
dc.identifier.uri.none.fl_str_mv http://hdl.handle.net/10554/53508
dc.identifier.doi.spa.fl_str_mv https://doi.org/10.1007/s11102-013-0536-7
dc.identifier.instname.spa.fl_str_mv instname:Pontificia Universidad Javeriana
dc.identifier.reponame.spa.fl_str_mv reponame:Repositorio Institucional - Pontificia Universidad Javeriana
dc.identifier.repourl.spa.fl_str_mv repourl:https://repository.javeriana.edu.co
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906559/
http://hdl.handle.net/10554/53508
https://doi.org/10.1007/s11102-013-0536-7
identifier_str_mv 1386-341X / 1573-7403 (Electrónico)
instname:Pontificia Universidad Javeriana
reponame:Repositorio Institucional - Pontificia Universidad Javeriana
repourl:https://repository.javeriana.edu.co
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationstartpage.spa.fl_str_mv 11
dc.relation.citationendpage.spa.fl_str_mv 17
dc.relation.ispartofjournal.spa.fl_str_mv Pituitary
dc.relation.citationvolume.spa.fl_str_mv 17
dc.relation.citationissue.spa.fl_str_mv 1
dc.rights.licence.*.fl_str_mv Atribución-NoComercial 4.0 Internacional
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc/4.0/
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv Atribución-NoComercial 4.0 Internacional
http://creativecommons.org/licenses/by-nc/4.0/
http://purl.org/coar/access_right/c_abf2
dc.format.spa.fl_str_mv PDF
dc.format.mimetype.spa.fl_str_mv application/pdf
institution Pontificia Universidad Javeriana
bitstream.url.fl_str_mv http://repository.javeriana.edu.co/bitstream/10554/53508/2/license.txt
http://repository.javeriana.edu.co/bitstream/10554/53508/1/Art%c3%adculo.pdf
http://repository.javeriana.edu.co/bitstream/10554/53508/3/Art%c3%adculo.pdf.jpg
bitstream.checksum.fl_str_mv 2070d280cc89439d983d9eee1b17df53
6bf8454dac1412d6b09f78f0840a0df8
286e6bd1f4e6ca68b6044e137589a3e2
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional - Pontificia Universidad Javeriana
repository.mail.fl_str_mv repositorio@javeriana.edu.co
_version_ 1814337839124447232
spelling Atribución-NoComercial 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc/4.0/http://purl.org/coar/access_right/c_abf2Vilar, LucioValenzuela, AlexRibeiro-Oliveira Jr, AntônioGomez Giraldo, Claudia MilenaPantoja, DolyBronstein, Marcello DPontificia Universidad Javeriana. Facultad de Medicina. Departamento de Endocrinología2021-04-13T02:08:01Z2021-04-13T02:08:01Z2013-11-23https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906559/1386-341X / 1573-7403 (Electrónico)http://hdl.handle.net/10554/53508https://doi.org/10.1007/s11102-013-0536-7instname:Pontificia Universidad Javerianareponame:Repositorio Institucional - Pontificia Universidad Javerianarepourl:https://repository.javeriana.edu.coPDFapplication/pdfengMultiple facets in the control of acromegalyArtículo de revistahttp://purl.org/coar/resource_type/c_6501Q2Q1Aims The current article provides a brief overview of the criteria for defining disease control in acromegaly. Methods This was a retrospective, narrative review of previously published evidence chosen at the author’s discretion along with an illustrative case study from Latin America. Findings and ConclusionsIn the strictest sense, “cure” in acromegaly is defined as complete restoration of normal pulsatile growth hormone secretion, although this is rarely achieved. Rather than “cure”, as such, it is more appropriate to refer to disease control and remission, which is defined mainly in terms of specific biochemical targets (for growth hormone and insulin-like growth factor-1) that predict or correlate with symptoms, comorbidities and mortality. However, optimal management of acromegaly goes beyond biochemical control to include control of tumour growth (which may be independent of biochemical control) and comprehensive management of the symptoms and comorbidities typically associated with the disease, as these may not be adequately managed with acromegaly-specific therapy alone.https://orcid.org/0000-0002-8433-5435N/AAcromegalyPituitaryLatin AmericaGHIGF-1Tumor shrinkageComorbiditiesSomatostatin analogs1117Pituitary171LICENSElicense.txtlicense.txttext/plain; charset=utf-82603http://repository.javeriana.edu.co/bitstream/10554/53508/2/license.txt2070d280cc89439d983d9eee1b17df53MD52open accessORIGINALArtículo.pdfArtículo.pdfapplication/pdf278192http://repository.javeriana.edu.co/bitstream/10554/53508/1/Art%c3%adculo.pdf6bf8454dac1412d6b09f78f0840a0df8MD51open accessTHUMBNAILArtículo.pdf.jpgArtículo.pdf.jpgIM Thumbnailimage/jpeg8856http://repository.javeriana.edu.co/bitstream/10554/53508/3/Art%c3%adculo.pdf.jpg286e6bd1f4e6ca68b6044e137589a3e2MD53open access10554/53508oai:repository.javeriana.edu.co:10554/535082021-10-22 14:55:37.901Repositorio Institucional - Pontificia Universidad Javerianarepositorio@javeriana.edu.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